We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Antigen Detection Test Guides Antibiotic Use

By LabMedica International staff writers
Posted on 18 Nov 2013
The effect of clinical scores that predict streptococcal infection or rapid streptococcal antigen detection tests were compared with delayed antibiotic prescribing.

Sore throat is one of the respiratory infections for which there are several reasonable diagnostic strategies for targeting antibiotics and rapid streptococcal antigen detection tests (RADTs) are one of the commonest near patient tests in clinical use internationally. More...
Clinical scores are also used to predict streptococcal infection used either alone or in combination with the antigen test.

Scientists at the University of Southampton (UK) recruited 631 patients with an acute sore throat and compared use of the FeverPAIN clinical score, with or without rapid antigen testing, with a delayed prescription, in which patients were told to pick up a prescription three to five days later if their symptoms did not settle or got worse. The FeverPAIN score includes fever in the past 24 hours, a pus infection, rapid attendance within three days, inflamed tonsils and no cough or cold symptoms.

The IMI test pack RADT (Inverness Medical; Bedford, UK) was used to detect Lancefield Group A Streptococcus based on in vitro performance and ease of use. The results showed that using the FeverPAIN score reduced antibiotic use by almost 30% and despite using fewer antibiotics, patients in the FeverPAIN score group experienced a greater improvement in symptoms. One in three patients in the FeverPAIN score group said their sore throat had improved rapidly from a moderately bad problem to a slight problem within two to four days. Moderately bad or worse symptoms also got better faster in the clinical score group.

However, the use of an in-practice rapid antigen test in conjunction with the FeverPAIN score did not result in any further reductions in antibiotic use or improvements in symptoms. The use of a rapid antigen test as well as the FeverPAIN test for patients who displayed streptococci symptoms did not offer any further improvements, with a 27% reduction in antibiotic use as well as similar improvements in patients' symptoms.

Michael Moore, MRCP, FRCGP, a coauthor of the study, said, “Clinicians can consider using a clinical score to target antibiotic use for acute sore throat, which is likely to reduce antibiotic use and improve symptom control. There is no clear advantage in the additional use of a rapid antigen test.” The study was published on October 10, 2013, in the journal British Medical Journal.

Related Links:

University of Southampton
Inverness Medical 



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.